Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension

por Lo, Arthur, Norcliffe-Kaufmann, Lucy, Vickery, Ross, Bourdet, David, Kanodia, Jitendra
Publicado 2021

Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond

por Sharma, Ashish, Sahasrabudhe, Vaishali, Musib, Luna, Zhang, Steven, Younis, Islam, Kanodia, Jitendra
Publicado 2021

A microfluidic array for large-scale ordering and orientation of embryos

por Chung, Kwanghun, Kim, Yoosik, Kanodia, Jitendra S., Gong, Emily, Shvartsman, Stanislav Y., Lu, Hang
Publicado 2010

Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain

por Kanodia, Jitendra, Lo, Arthur, Baldwin, R. Michael, Graham, Richard A., Bourdet, David L.
Publicado 2020

Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles

por Kanodia, Jitendra, Chai, Diana, Vollmer, Jannik, Kim, Jaeyeon, Raue, Andreas, Finn, Greg, Schoeberl, Birgit
Publicado 2014

Safety, Pharmacokinetics, and Pharmacodynamics of TD‐0714, a Novel Potent Neprilysin Inhibitor in Healthy Adult and Elderly Subjects

por Kanodia, Jitendra, Lo, Arthur, Baldwin, R. Michael, Colley, Ken, Zhou, Kefei, Bourdet, David L.
Publicado 2020

Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial

por Kaufmann, Horacio, Vickery, Ross, Wang, Whedy, Kanodia, Jitendra, Shibao, Cyndya A., Norcliffe-Kaufmann, Lucy, Haumann, Brett, Biaggioni, Italo
Publicado 2021

International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs

por Pruimboom‐Brees, Ingrid M., Gupta, Swati, Chemuturi, Nagendra, Booler, Helen S., Nimz, Erik, Ferrell Ramos, Meg, Caruso, Antonello, Maass, Katie F., Bantseev, Vladimir, Huang, Qihong, Choules, Mary P., Nussbaum, Jesse C., Kanodia, Jitendra, Thompson, Christopher, Durairaj, Chandrasekar
Publicado 2023

Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia

por Ravandi, Farhad, Bashey, Asad, Foran, James, Stock, Wendy, Mawad, Raya, Short, Nicholas, Yilmaz, Musa, Kantarjian, Hagop, Odenike, Olatoyosi, Patel, Anand, Garcha, Raman, Ainsworth, William Barrett, Clynes, Raphael, Kanodia, Jitendra, Ding, Ying, Li, Huajiang, Kye, Steve, Mims, Alice
Publicado 2023

Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

por Tom, Irene, Pham, Victoria C., Katschke, Kenneth J., Li, Wei, Liang, Wei-Ching, Gutierrez, Johnny, Ah Young, Andrew, Figueroa, Isabel, Eshghi, Shadi Toghi, Lee, ChingWei V., Kanodia, Jitendra, Snipas, Scott J., Salvesen, Guy S., Lai, Phillip, Honigberg, Lee, van Lookeren Campagne, Menno, Kirchhofer, Daniel, Baruch, Amos, Lill, Jennie R.
Publicado 2020